hydroxychloroquinefda[.]com

This domain, hydroxychloroquinefda.com, was registered on April 24, 2026, through Fewmoretaps OU operating under Trustname.com. Analysis indicates it is part of a phishing infrastructure targeting individuals searching for regulatory-approved medications. The domain remains active as of July 12, 2026, resolving to an IP address (3.71.180.249) hosted on AWS EC2 in Germany, specifically within the eu-central-1 region. The site currently returns an HTTP 403 status, suggesting access restrictions or a placeholder configuration, though this does not preclude malicious activity behind the scenes. Infrastructure review reveals the domain uses nameservers ares.trustname.com and zeus.trustname.com, both associated with the same registrar. It has been flagged by at least one security blocklist and appears in two threat intelligence pulses on AlienVault OTX, reinforcing its classification as malicious. While only three out of ninety-five security vendors on VirusTotal currently detect this domain, the presence of a Let's Encrypt SSL certificate (R13) may lend a false sense of legitimacy to unsuspecting visitors. The domain's naming convention—combining a pharmaceutical term with 'FDA'—strongly suggests an intent to impersonate regulatory or healthcare authorities. This tactic is commonly used to exploit public interest in medical treatments, particularly during periods of heightened health concerns. Defenders should note that the domain's creation date aligns with recurring phishing campaigns observed in 2026, though no specific brand impersonation or phishing kit has been confirmed at this time. Organizations and individuals are advised to block this domain at the network level and monitor for related infrastructure, particularly domains registered through the same registrar or resolving to the same IP range. Given its persistent active status and presence on threat intelligence platforms, further malicious activity from this domain or associated assets remains likely.